Nuclear Factor-erythroid 2 (NF-E2) p45-related Factor-2 (Nrf2) Modulates Dendritic Cell Immune Function through Regulation of p38 MAPK-cAMP-responsive Element Binding Protein/Activating Transcription Factor 1 Signaling
Laith M Abbas Al-Huseini(University of Liverpool), Jean G. Sathish(Pfizer (United States))
Cited by 54
Related Papers
Loss of Transcription Factor Nuclear Factor-Erythroid 2 (NF-E2) p45-related Factor-2 (Nrf2) Leads to Dysregulation of Immune Functions, Redox Homeostasis, and Intracellular Signaling in Dendritic Cells
|Journal of Biological Chemistry|2012|91
Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studies
|mAbs|2025|30
Beyond MABEL: An Integrative Approach to First in Human Dose Selection of Immunomodulators by the Health and Environmental Sciences Institute (HESI) Immuno‐Safety Technical Committee (ITC)
|Clinical Pharmacology & Therapeutics|2024|15
Abstract LB-B33: Nonclinical safety evaluation of two distinct second generation variants of anti-CTLA4 monoclonal antibody, ipilimumab, in monkeys
|Molecular Cancer Therapeutics|2018|11